Makoto Kurano et al.
Clinical and translational medicine, 12(10), e1069-e1069 (2022-10-11)
A heterogeneous clinical phenotype is a characteristic of coronavirus disease 2019 (COVID-19). Therefore, investigating biomarkers associated with disease severity is important for understanding the mechanisms responsible for this heterogeneity and for developing novel agents to prevent critical conditions. This study